FINWIRES · TerminalLIVE
FINWIRES

Orion Minerals Says IDC Converts 344.5 Million South African Rand Loan Into Equity in Prieska Project

By

Orion Minerals (ASX:ORN) said the Industrial Development Corporation of South Africa (IDC) converted its about 344.5 million South African Rand convertible loan facility into equity in unit PCZM HoldCo, becoming a 23.8% shareholder in PCZM HoldCo and giving it an effective interest of about 16.7% in PCZM, according to a Friday Australian bourse filing.

The company said the IDC retains a shareholder loan claim against PCZM HoldCo of about 272.4 million South African Rand, with all security granted in connection with the facility agreement released following the conversion.

The IDC, as a long-standing development finance partner, becomes a direct shareholder in PCZM HoldCo, deepening its strategic alignment with the Prieska project, the filing added.

Related Articles

Asia

AusQuest to Begin New Phase of Diamond Drilling at Peru Porphyry Copper-Gold Project

AusQuest (ASX:AQD) is set to begin a new phase of diamond drilling of over 5,000 meters at the Cangallo porphyry copper-gold project in Peru to test for higher-grade mineralization, according to a Friday Australian bourse filing.It also said stage three reverse circulation drilling at the project highlighted extensive copper-gold mineralization from near surface. It encountered intercepts of 176 meters at 0.38% grade of copper and 0.07 grams per tonne grade of gold from 40 meters, as well as 236 meters at 0.3% copper and 0.08 g/t grade of gold from two meters.

$ASX:AQD
Asia

Market Chatter: Japanese Hotel Rates Hit Record High in April as US and European Tourists Surge, Chinese Visitors Decline

Average hotel room rates in Japan hit a new April record of 23,397 yen, rising 4.6% from last year's high, Nikkei Asia reported Friday, citing data from STR, a CoStar Group subsidiary.The growth was driven by strong inbound demand from travelers in the U.S., Europe, and Australia, the report said.In contrast, Chinese visitor numbers dropped as Beijing continued to discourage travel to Japan over political tensions, the news daily said.Highlighting the sustained demand, Nikkei noted a tour guide managing two- to three-week itineraries across Tokyo, Kyoto, and Hiroshima, with many of those bookings made more than a year in advance.Hotel demand stayed robust throughout cherry blossom season, supported by favorable weather, Nikkei said.The weak yen also provided a boost in April compared with last year, the report said, citing hotel operator Hilton.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$^N225
Asia

Innovent Biologics Enters Licensing Agreement With Pfizer for 12 Oncology Programs

Innovent Biologics (HKG:1801) agreed to license 12 early-stage cancer therapy programs to Pfizer for an upfront payment of $650 million, according to a Friday filing with the Hong Kong bourse.The 12 oncology programs comprise eight Innovent-originated early-stage assets and four Pfizer-proposed discovery programs.Under the agreement, Innovent will advance development of the assets through phase 1 clinical study, after which Pfizer will lead global development.In addition to the upfront payment, Innovent is eligible to receive up to $9.85 billion in milestone payments, plus royalties on products that are commercialized.

$HKG:1801